Introduction: No reflow during primary angioplasty is associated with a poor prognosis despite the reopening of the culprit coronary. The aim of our work was to determine the predictive factors of noreflow. Methodology: Single-center retrospective analytical study from June 2000 to December 2016 that included patients presenting with STEMI took care of by primary angioplasty. No reflow was defined according to angiographic criteria: a TIMI flow < 3 (regardless of the Myocardial Blush Grade) or TIMI flow at 3 with MBG ≤ 1, patients were divided into two groups, one group with no reflow and a second group without no reflow. Clinical and angiographic data were compared between the two groups. Univariate and multivariate analysis was performed to determine the predictors of no reflow. Results: The prevalence？of no reflow was 24%. In univariate analysis mean age, diabetes,hypertension, tachycardia, hypotension, killip stage 4 left ventricular failure, hyperglycemia > 11, renal failure, left ventricular dysfunction, tritruncal status, common trunk involvement, initial TIMI flow at 0, significant thrombotic load, delay to angioplasty > 6 hours, and predilation were all correlated with no reflow with a p < 0. 05. In multivariate analysis age > 75 years [OR = 6.02, 95% CI 1.4 - 27, p = 0.014], tachycardia [OR = 4.3, 95% CI 1.6 - 7.4, p = 0.037], delay to angioplasty > 6 hours [OR = 1.3, 95% CI 1.1 - 2.1, p = 0.003] and high thrombotic load [OR = 1.5, 95% CI 1.3 - 3.2, p = 0.02] were independent predictors of no reflow. Conclusion: No reflow is associated with a poor short-term prognosis. Its care requires knowledge of predictive factors, prevention and treatment.
References
[1]
Kloner, R.A., Ganote, C.E. and Jennings, R.B. (1974) The “No-Reflow” Phenomenon after Temporary Occlusion in the Dog. The Journal of Clinical Investigation, 54, 1496-1508. https://doi.org/10.1172/JCI107898
[2]
Gupta, S. and Gupta, M.M. (2016) No Reflow Phenomenon in Percutaneous Coronary Interventions in ST-Segment Elevation Myocardial Infarction. Indian Heart Journal, 68, 539-551. https://doi.org/10.1016/j.ihj.2016.04.006
Rezkalla, S.H., Stankowski, R.V., Hanna, J. and Kloner, R.A. (2017) Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC: Cardiovascular Interventions, 10, 215-223. https://doi.org/10.1016/j.jcin.2016.11.059
[5]
Bouleti, C., Mewton, N. and Germain, S. (2015) The No-Reflow Phenomenon: State of the Art. Archives of Cardiovascular Diseases, 108, 661-674.
https://doi.org/10.1016/j.acvd.2015.09.006
[6]
Durante, A. and Camici, P.G. (2015) Novel Insights into an “Old” Phenomenon: The No Reflow. International Journal of Cardiology, 187, 273-280.
https://doi.org/10.1016/j.ijcard.2015.03.359
[7]
Rezkalla, S.H., Dharmashankar, K.C., Abdalrahman, I.B. and Kloner, R.A. (2010) No-Reflow Phenomenon Following Percutaneous Coronary Intervention for Acute Myocardial Infarction: Incidence, Outcome, and Effect of Pharmacologic Therapy. Journal of Interventional Cardiology, 23, 429-436.
https://doi.org/10.1111/j.1540-8183.2010.00561.x
[8]
Chettibi, M., Benghezel, S., Nemmar, N., Nedjar, R., Bouraghda, M.A. and Bouafia, M.T.C. (2014) Etude des facteurs prédictifs de “no reflow” à la phase aigue des sca avec sus décalage de ST. Cardiologie Tunisienne, 10, 175-183.
[9]
Charfeddine, S., Ellouze, T., Abid, L., Hammami, R., Hamza, C., Maalej, A., et al. (2017) Prise en charge de l’infarctus du myocarde avec sus décalage persistant du segment ST: étude prospective à propos de 215 patients. Cardiologie Tunisienne, 13, 11-17.
[10]
Zhou, H., He, X.-Y., Zhuang, S.-W., Wang, J., Lai, Y., Qi, W.-G., et al. (2014) Clinical and Procedural Predictors of No-Reflow in Patients with Acute Myocardial Infarction after Primary Percutaneous Coronary Intervention. World Journal of Emergency Medicine, 5, 96-102.
https://doi.org/10.5847/wjem.j.issn.1920-8642.2014.02.003
[11]
Fajar, J.K., Heriansyah, T. and Rohman, M.S. (2018) The Predictors of No Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Meta-Analysis. Indian Heart Journal, 70, 406-418.
https://doi.org/10.1016/j.ihj.2018.01.032
[12]
Jousilahti, P., Vartiainen, E., Tuomilehto, J. and Puska, P. (1999) Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease: A Prospective Folow-Up Study of 14786 Middle-Aged Men and Woman in Finland. Circulation, 99, 1165-1172.
https://doi.org/10.1161/01.CIR.99.9.1165
[13]
Celermajer, D.S., Sorensen, K.E., Spiegelhalter, D.J., Georgakopoulos, D., Robinson, J. and Deanfield, J.E. (1994) Aging Is Associated with Endothelial Dysfunction in Healthy Men Years before the Age-Related Decline in Women. JACC: Journal of the American College of Cardiology, 24, 471-476.
https://doi.org/10.1016/0735-1097(94)90305-0
[14]
Tabit, C.E., Chung, W.B., Hamburg, N.M. and Vita, J.A. (2010) Endothelial Dysfunction in Diabetes Mellitus: Molecular Mechanisms and Clinical Implications. Reviews in Endocrine and Metabolic Disorders, 11, 61-74.
https://doi.org/10.1007/s11154-010-9134-4
[15]
Carballo, S., Carballo, D., Keller, P.F. and Roffi, M. (2011) Spécificités du diabète dans le syndrome coronarien aigu. Revue Médicale Suisse, 7, 1200-1206.
[16]
Iwakura, K., Ito, H., Ikushima, M., Kawano, S., Okamura, A., Asano, K., et al. (2003) Association between Hyperglycemia and the No-Reflow Phenomenon in Patients with Acute Myocardial Infarction. Journal of the American College of Cardiology, 41, 1-7. https://doi.org/10.1016/S0735-1097(02)02626-8
[17]
Oswald, G.A. and Yudkin, J.S. (1987) Hyperglycaemia Following Acute Myocardial Infarction: The Contribution of Undiagnosed Diabetes. Diabetic Medicine, 4, 68-70.
https://doi.org/10.1111/j.1464-5491.1987.tb00833.x
[18]
Malmberg, K., Ryden, L., Efendic, S., et al. (1995) Randomized Trial of Insulin- Glucose Infusion Followed by Subcutaneous Insulin Treatment in Diabetic Patients with Acute Myocardial Infarction (DIGAMI Study): Effects on Mortality at 1 Year. Journal of the American College of Cardiology, 26, 57-65.
https://doi.org/10.1016/0735-1097(95)00126-K
[19]
Tansey, M.J. and Opie L.H. (1986) Plasma Glucose on Admission to Hospital as a Metabolic Index of the Severity of Acute Myocardial Infarction. Canadian Journal of Cardiology, 2, 326-331.
[20]
Capes, S.E., Hunt, D., Malmberg, K. and Gerstein, H.C. (2000) Stress Hyperglycemia and Increased Risk of Death after Myocardial Infarction in Patients with and without Diabetes: A Systematic Overview. Lancet, 355, 773-778.
https://doi.org/10.1016/S0140-6736(99)08415-9
[21]
Marfella, R., Esposito, K., Giunta, R., Coppola, G., De Angelis, L., Farzati, B., et al. (2000) Circulating Adhesion Molecules in Humans: Role of Hyperglycemia and Hyperinsulinemia. Circulation, 101, 2247-2251.
https://doi.org/10.1161/01.CIR.101.19.2247
[22]
Booth, G., Stalker, T.J., Lefer, A.M. and Scalia, R. (2001) Elevated Ambient Glucose Induces Acute Inflammatory Events in the Microvasculature: Effects of Insulin. American Journal of Physiology-Endocrinology and Metabolism, 280, 848-856.
https://doi.org/10.1152/ajpendo.2001.280.6.E848
[23]
Hokama, J.Y., Ritter, L.S., Davis-Gorman, G., Cimetta, A.D., Copeland, J.G. and McDonagh, P.F. (2000) Diabetes Enhances Leukocyte Accumulation in the Coronary Microcirculation Early in Reperfusion Following Ischemia. Journal of Diabetes and its Complications, 14, 96-107. https://doi.org/10.1016/S1056-8727(00)00068-4
[24]
Engler, R.L., Dahlgren, M.D., Morris, D.D., Peterson, M.A. and Schmid-Schonbein, G.W. (1986) Role of Leukocytes in Response to Acute Myocardial Ischemia and Reflow in Dogs. American Physiological Society Journal, 251, 314-323.
https://doi.org/10.1152/ajpheart.1986.251.2.H314
[25]
Montalescot, G., Barragan, P., Wittenberg, O., Ecollan, P., Elhadad, S., Vilain, P., et al. (2001) Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction. The New England Journal of Medicine, 344, 1895-1903.
https://doi.org/10.1056/NEJM200106213442503
[26]
Shechter, M., Merz, C.N., Paul-Labrador, M.J. and Kaul, S. (2000) Blood Glucose and Platelet-Dependent Thrombosis in Patients with Coronary Artery Disease. Journal of the American College of Cardiology, 35, 300-307.
https://doi.org/10.1016/S0735-1097(99)00545-8
[27]
Iwakura, K., Ito, H., Kawano, S., Shintani, Y., Yamamoto, K., Kato, A., et al. (2001) Predictive Factors for Development of the No-Reflow Phenomenon in Patients with Reperfused Anterior Wall Acute Myocardial Infarction. Journal of the American College of Cardiology, 38, 472-477. https://doi.org/10.1016/S0735-1097(01)01405-X
[28]
Kersten, J.R., Schmeling, T.J., Orth, K.G., Pagel, P.S. and Waltier, D.C. (1998) Acute Hyperglycemia Abolishes Ischemic Preconditioning in Vivo. American Journal of Physiology Heart and Circulatory Physiology, 275, 721-725.
https://doi.org/10.1152/ajpheart.1998.275.2.H721
[29]
Kersten, J.R., Montogomery, M.W., Ghassemi, T., et al. (2001) Diabetes and Hyperglycemia Impair Activation of Mitochondrial KATP Channels. American Journal of Physiology Heart and Circulatory Physiology, 280, 1744-1750.
https://doi.org/10.1152/ajpheart.2001.280.4.H1744
[30]
Kersten, J.R., Toller, W.G., Tessmer, J.P., Pagel, P.S. and Waltier, D.C. (2001) Hyperglycemia Reduces Coronary Collateral Blood Flow through a Nitric Oxide–Mediated Mechanism. American Journal of Physiology Heart and Circulatory Physiology, 281, 2097-2104. https://doi.org/10.1152/ajpheart.2001.281.5.H2097
[31]
Gillum, R.F., Makuc, D.M. and Feldman, J.J. (1991) Pulse Rate, Coronary Heart Disease, and Death: The NHANES I Epidemiologic Follow-Up Study. American Heart Journal, 121, 172-177. https://doi.org/10.1016/0002-8703(91)90970-S
[32]
Kjekshus, J. and Gullestad, L. (1999) Heart Rate as a Therapeutic Target in Heart Failure. European Heart Journal Supplements, 1, 64-69.
[33]
Kirma, C., Izgi, A., Dundar, C., Tanalp, A.C., Oduncu, V., Aung, S.M., et al. (2008) Clinical and Procedural Predictors of No Reflow Phenomenon after Primary Percutaneous Coronary Interventions: Experience at a Single Center. Circulation Journal, 72, 716-721. https://doi.org/10.1253/circj.72.716
[34]
Beyersdorf, F., Buckberg, G.D., Acar, C., Okamoto, F., Sjostrand, F., Young, H., et al. (1989) Cardiogenic Shock after Acute Coronary Occlusion: Pathogenesis, Early Diagnosis, and Treatment. The Journal of Thoracic and Cardiovascular Surgery, 37, 28-36. https://doi.org/10.1055/s-2007-1013901
[35]
Reynolds, H.R. and Hochman, J.S. (2008) Cardiogenic Shock: Current Concepts and Improving Outcomes. Circulation, 117, 686-697.
https://doi.org/10.1161/CIRCULATIONAHA.106.613596
[36]
Hearse, D.J. and Bolli, R. (1992) Reperfusion Induced Injury: Manifestations, Mechanisms, and Clinical Relevance. Cardiovascular Research, 26, 101-108.
https://doi.org/10.1093/cvr/26.2.101
[37]
Ali, A., Cox, D., Dib, N., Brodie, B., Berman, D., Gupta, N., et al. (2006) Rheolytic Thrombectomy with Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarct Size Reduction in Acute Myocardial Infarction: 30-Day Results from a Multicenter Randomized Study. Journal of the American College of Cardiology, 48, 244-252. https://doi.org/10.1016/j.jacc.2006.03.044
[38]
Nagata, Y., Usuda, K., Uchiyama, A., Uchikoshi, M., Sekiguchi, Y., Kato, H., et al. (2004) Characteristics of the Pathological Images of Coronary Artery Thrombi According to the Infarct-Related Coronary Artery in Acute Myocardial Infarction. Circulation Journal, 68, 308-314. https://doi.org/10.1253/circj.68.308
[39]
Yip, H.K., Chen, M.C., Chang, H.W., Hang, C.L., Hsieh, Y.K., Fang, C.Y., et al. (2002) Angiographic Morphologic Features of Infarct-Related Arteries and Timely Reperfusion in Acute Myocardial Infarction: Predictors of Slow-Flow and No-Flow. Chest, 122, 1322-1332. https://doi.org/10.1378/chest.122.4.1322
[40]
Niccoli, G., Scalone, G., Lerman, A. and Crea, F. (2016) Coronary Microvascular Obstruction in Acute Myocardial Infarction. European Heart Journal, 37, 1024-1033.
https://doi.org/10.1093/eurheartj/ehv484
[41]
Choo, E.H., Kim, P.J., Chang, K., Ahn, Y., Jeon, D.S., Lee, J.M., et al. (2014) The Impact of No-Reflow Phenomena after Primary Percutaneous Coronary Intervention: A Time-Dependent Analysis of Mortality. Coronary Artery Disease, 25, 392-398.
https://doi.org/10.1097/MCA.0000000000000108
[42]
Frederic, S.R., Marco, W., Michael, K.Y., Dominik, B., Rodrigo, V.W., Lucila, O., et al. (2003) No-Reflow Is an Independent Predictor of Death and Myocardial Infarction after Percutaneous Coronary Intervention. American Heart Journal, 145, 42-46.
https://doi.org/10.1067/mhj.2003.36
